Skip to main content
. 2020 Dec 2;41(1):3–15. doi: 10.1002/cac2.12118

FIGURE 1.

FIGURE 1

PRISMA flow diagram of the selection of studies on the clinical applications of cfDNA in EC. PRISMA = Preferred Reporting Items for Systematic Reviews and Meta‐analyses, cfDNA = circulating cell‐free DNA, EC = esophageal cancer